HEADER ANTIFUNGAL PROTEIN 29-AUG-19 6U6G TITLE SOLUTION NMR STRUCTURE OF THE NODULE-SPECIFIC CYSTEINE-RICH PEPTIDE TITLE 2 NCR044 FROM MEDICAGO TRUNCATULA COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE LATE NODULIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MEDICAGO TRUNCATULA; SOURCE 3 ORGANISM_COMMON: BARREL MEDIC; SOURCE 4 ORGANISM_TAXID: 3880; SOURCE 5 GENE: MTRUNA17_CHR7G0216231; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS FUNGAL DISEASE, ANTIFUNGAL AGENT, ANTIFUNGAL PROTEIN, DEFENSIN-LIKE EXPDTA SOLUTION NMR NUMMDL 19 AUTHOR S.L.S.VELIVELLI,G.W.BUCHKO,D.M.SHAH REVDAT 4 27-MAR-24 6U6G 1 SOURCE AUTHOR REVDAT 3 14-JUN-23 6U6G 1 REMARK REVDAT 2 21-OCT-20 6U6G 1 JRNL REVDAT 1 09-OCT-19 6U6G 0 JRNL AUTH S.L.S.VELIVELLI,K.J.CZYMMEK,H.LI,J.B.SHAW,G.W.BUCHKO, JRNL AUTH 2 D.M.SHAH JRNL TITL ANTIFUNGAL SYMBIOTIC PEPTIDE NCR044 EXHIBITS UNIQUE JRNL TITL 2 STRUCTURE AND MULTIFACETED MECHANISMS OF ACTION THAT CONFER JRNL TITL 3 PLANT PROTECTION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 117 16043 2020 JRNL REFN ESSN 1091-6490 JRNL PMID 32571919 JRNL DOI 10.1073/PNAS.2003526117 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION WAS PERFORMED REMARK 3 ITERATIVELY USING CYANA (AUTOMATED NOESY ASSIGNMENTS). A TOTAL REMARK 3 OF 20 STRUCTURES OUT OF 100 WITH LOWEST TARGET FUNCTION FROM THE REMARK 3 FINAL CYANA CALCULATION WERE TAKEN AND REFINED BY RESTRAINED REMARK 3 MOLECULAR DYNAMICS/ENERGY MINIMIZATION IN EXPLICIT WATER (CNS) REMARK 3 AFTER ADDING 0% TO THE UPPER BOUNDARY LIMIT OF THE DISTANCE REMARK 3 RESTRAINTS AND THE VDW LIMIT TO THE LOWER RESTRAINT. PARAM19 WAS REMARK 3 USED FOR THE WATER REFINEMENT CALCULATIONS. DISULFIDE BOND REMARK 3 RESTRAINTS WERE IDENTIFIED BY MASS SPECTROMETER AND ARE INCLUDED REMARK 3 IN THE "NOE" FILE. REMARK 4 REMARK 4 6U6G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1000244022. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 5.4 REMARK 210 IONIC STRENGTH : 70 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 50 MM SODIUM CHLORIDE, 20 MM REMARK 210 SODIUM ACETATE, 1 MM [U-99% 13C; REMARK 210 U-99% 15N] DEF19, 93% H2O/7% D2O; REMARK 210 50 MM SODIUM CHLORIDE, 20 MM REMARK 210 SODIUM ACETATE, 1 MM [U-99% 13C; REMARK 210 U-99% 15N] DEF19-2, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCO; 3D REMARK 210 HNCACB; 3D C(CO)NH; 2D 1H-13C REMARK 210 HSQC ALIPHATIC; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 3D 1H-15N NOESY; REMARK 210 DEUTERIUM EXCHANGE; 3D H(CCO)NH REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : INOVA; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY 3.13, CYANA 2.1, FELIX REMARK 210 2007, PSVS 1.5 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 19 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 8 -178.18 -64.86 REMARK 500 1 ASN A 20 -8.11 77.88 REMARK 500 2 ILE A 3 109.33 -58.19 REMARK 500 2 LYS A 19 42.71 -104.22 REMARK 500 2 TYR A 21 81.73 53.92 REMARK 500 3 PHE A 2 76.15 -109.70 REMARK 500 3 ILE A 17 83.99 -67.90 REMARK 500 3 ASN A 20 39.28 -81.06 REMARK 500 4 LEU A 5 119.95 -163.55 REMARK 500 4 PRO A 8 -155.01 -65.00 REMARK 500 4 ILE A 17 -75.87 -96.64 REMARK 500 4 ASN A 20 -77.69 -171.41 REMARK 500 5 ILE A 3 34.88 -90.37 REMARK 500 5 GLN A 4 66.40 -117.29 REMARK 500 5 PRO A 8 -151.24 -70.37 REMARK 500 5 SER A 16 85.46 -67.74 REMARK 500 5 ILE A 17 -168.81 -118.53 REMARK 500 5 ARG A 26 144.62 -170.98 REMARK 500 6 ILE A 3 31.35 -86.27 REMARK 500 6 ARG A 34 92.55 -65.76 REMARK 500 7 ILE A 3 41.29 -87.81 REMARK 500 7 VAL A 18 29.34 40.58 REMARK 500 8 PHE A 2 76.15 -104.98 REMARK 500 8 SER A 16 81.56 -69.16 REMARK 500 8 TYR A 21 17.77 53.91 REMARK 500 8 ILE A 35 33.27 -75.27 REMARK 500 9 SER A 16 85.57 -68.56 REMARK 500 9 ARG A 33 89.41 -68.21 REMARK 500 10 ILE A 17 -34.02 -131.65 REMARK 500 11 PRO A 8 -158.90 -80.22 REMARK 500 12 PRO A 8 167.30 -49.87 REMARK 500 12 VAL A 18 -65.17 37.21 REMARK 500 13 VAL A 18 9.91 58.32 REMARK 500 14 PRO A 8 -171.49 -69.37 REMARK 500 14 CYS A 15 48.71 -88.62 REMARK 500 14 VAL A 18 91.05 32.40 REMARK 500 15 PRO A 8 -176.03 -68.80 REMARK 500 15 VAL A 18 76.43 -105.50 REMARK 500 15 LYS A 19 56.71 -148.39 REMARK 500 15 ASN A 20 -64.81 73.88 REMARK 500 15 ARG A 34 -58.57 -157.57 REMARK 500 16 TYR A 21 171.38 -52.62 REMARK 500 17 PRO A 8 -168.20 -72.51 REMARK 500 17 SER A 16 81.71 -68.25 REMARK 500 18 ARG A 22 85.41 -151.21 REMARK 500 18 ARG A 26 126.87 -170.87 REMARK 500 18 ARG A 34 -165.97 -103.74 REMARK 500 19 VAL A 18 24.84 40.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30660 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF THE NODULE-SPECIFIC CYSTEINE-RICH PEPTIDE REMARK 900 NCR044 FROM MEDICAGO TRUNCATULA DBREF1 6U6G A 1 36 UNP A0A396GSL0_MEDTR DBREF2 6U6G A A0A396GSL0 33 68 SEQRES 1 A 36 ALA PHE ILE GLN LEU SER LYS PRO CYS ILE SER ASP LYS SEQRES 2 A 36 GLU CYS SER ILE VAL LYS ASN TYR ARG ALA ARG CYS ARG SEQRES 3 A 36 LYS GLY TYR CYS VAL ARG ARG ARG ILE ARG HELIX 1 AA1 SER A 16 ASN A 20 5 5 SHEET 1 AA1 2 ARG A 24 ARG A 26 0 SHEET 2 AA1 2 TYR A 29 VAL A 31 -1 O VAL A 31 N ARG A 24 SSBOND 1 CYS A 9 CYS A 30 1555 1555 2.22 SSBOND 2 CYS A 15 CYS A 25 1555 1555 2.22 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1